Daniel Kenny has almost 30 years of experience in the global pharmaceutical and medical device industry. He is an accomplished and proven biopharmaceutical business leader and in his career, he has developed and successfully driven business with industry leaders such as Roche, Allergan and Baxter working in Australia, EMEA and the US. Prior to joining OncoSil Medical in 2015, Mr Kenny was chief commercial officer of ABIVAX, a Paris-based global biopharmaceutical company specialising in the development of novel vaccines and anti-virals. At Baxter, he was global franchise head of vaccines and oversaw all franchise operations. Prior to that role, Mr Kenny was vice president of Baxter BioScience, EMEA with responsibility for all marketing and key business programmes in support of regional sales exceeding $1.9bio. He also served with Roche as global lifecycle leader for Roaccutance, a product generating sales in excess of CHF 1.1 bio (2002), assuming responsibility for all global strategic marketing and business development activities. He was also international medical manager and medical science and safety team leader responsible for post-NDA clinical development strategy and critical issue work-ups for regulatory authorities. Mr Kenny completed over 10 years in clinical research in the fields of ophthalmology with the Royal Australian College of Ophthalmologists and the University of Sydney and HIV/AIDS research at the University of New South Wales, Sydney, Australia prior to joining the pharmaceutical industry. He is a graduate in Physics from the University of New South Wales and has completed Executive Business Studies at both INSEAD and London Business School. He is a graduate of the Australian Institute of Physics and a member of the Australian Institute of Company Directors.
Bio last updated 04 Jun 2018
BNiQ Network Graph
Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.